TRAW Stock Catalyst: Traws Pharma Criticized by Chuck Schumer Amid Hantavirus Scare

May 11, 2026 · 9:41am ET

Criticism centers on firing of CDC and port health workers.

Max move

+45.5%

High of day $3.23

Sparker timei

9:41am ET

TRAW · May 11, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Traws Pharma, Inc. (Nasdaq: TRAW) faced criticism from Chuck Schumer, who publicly condemned actions by Trump and Elon Musk to dismiss CDC and port health workers during a global Hantavirus scare. The criticism highlights concerns over public health safety measures.

No financial amounts or filings were associated with this announcement. The free float of Traws Pharma stands at 5,364,555 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time TRAW sparks.

Download Sniper App →

Catch the next TRAW-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →